Interlaboratory variation in the detection of HPA-specific alloantibodies and in molecular HPA typing

Vox Sanguinis

Volumn 93, Issue 4, 2007, Pages 316-324

  Allen, D ^a   Ouwehand, W H ^b   De Haas, M ^c,d   Kekomaki, R ^e   Kaplan, C ^f   Metcalfe, P ^g  

^a NHS BLOOD AND TRANSPLANT   (United Kingdom)

^b UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^c SANQUIN RESEARCH   (Netherlands)

^d UNIVERSITY OF AMSTERDAM   (Netherlands)

^e FINNISH RED CROSS BLOOD SERVICE   (Finland)

^f INSTITUT NATIONAL DE LA TRANSFUSION SANGUINE   (France)

^g NATIONAL INSTITUTE FOR BIOLOGICAL STANDARDS AND CONTROL   (United Kingdom)

Author keywords

HPA antibodies; HPA genotyping; PCR SSP

Indexed keywords

THROMBOCYTE ANTIGEN;

ANEMIA; ANTIBODY DETECTION; ANTIBODY SPECIFICITY; ARTICLE; BLOOD TRANSFUSION; GENOTYPE; HUMAN; IMMUNOASSAY; PRIORITY JOURNAL; QUALITY CONTROL; SEROLOGY;

ANTIBODIES, MONOCLONAL; ANTIBODY SPECIFICITY; ANTIGENS, HUMAN PLATELET; BLOOD BANKS; BLOOD PLATELETS; EUROPE; GENOTYPE; HUMANS; IMMUNOASSAY; ISOANTIBODIES; QUALITY CONTROL; REFERENCE STANDARDS; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY;

EID: 36248937687     PISSN: 00429007     EISSN: 14230410     Source Type: Journal    
DOI: 10.1111/j.1423-0410.2007.00960.x     Document Type: Article

References (17)

1. Metcalfe P, Ouwehand WH, Sands D, Barrowcliffe TW:Collaborative studies to establish the first WHO Reference Reagent for detection of human antibody against human platelet antigen-5b. Vox Sang 2003 84:237 240
2. Berry J, Allen D, Porcelijn L, de Haas M, Kekomaki R, Kaplan C, Ouwehand WH, Metcalfe P:Collaborative studies to establish the first World Health Organization International Standard for detection of human antibody against human platelet antigen-3a. Vox Sang 2007 93:309 315
3. Allen DL, Chapman J, Phillips PK, Ouwehand WH:Sensitivity of the platelet immunofluorescence test (PIFT) and the MAIPA assay for the detection of platelet-reactive alloantibodies: a report on two UK National Platelet Workshop exercises. Transfus Med 1994 4:157 164
4. Metcalfe P, Allen D, Chapman J, Ouwehand WH:Interlaboratory variation in the detection of clinically significant alloantibodies against human platelet alloantigens. Br J Haematol 1997 97:204 207
5. Lin M, Shieh SH, Liang DC, Yang TF, Shibata Y:Neonatal alloimmune thrombocytopenia in Taiwan due to an antibody against a labile component of HPA-3a (Baka). Vox Sang 1995 69:336 340
6. Harrison CR, Curtis BR, McFarland JG, Huff RW, Aster RH:Severe neonatal alloimmune thrombocytopenia caused by antibodies to human platelet antigen 3a (Baka) detectable only in whole platelet assays. Transfusion 2003 43:1398 1402
7. Foxcroft Z, Campbell K, Merieux Y, Urbaniak S, Brierley M, Rigal D, Ouwehand WH, Metcalfe P:Report on the 13th International Society of Blood Transfusion Platelet Immunology Workshop. Vox Sang 2007 93:300 305
8. Platelet Immunology:Guidelines for the Blood Transfusion Services in the UK, 7th edn. Norwich, TSO, 2005 17:216 219
9. Ertel K, Al Tawil M, Santoso S, Kroll H:Relevance of the HPA-15 (Gov) polymorphism on CD109 in alloimmune thrombocytopenic syndromes. Transfusion 2005 45:366 373
10. Agildere A, Wernet D, Schnaidt M:Limits of the MAIPA assay when differentiating high-titered platelet-reactive antibodies. Beitr Infusionsther Transfusionsmed 1997 34:190 193
11. Berry JE, Murphy CM, Smith GA, Ranasinghe E, Finberg R, Walton J, Brown J, Navarrete C, Metcalfe P, Ouwehand WH:Detection of Gov system antibodies by MAIPA reveals an immunogenicity similar to the HPA-5 alloantigens. Br J Haematol 2000 110:735 742
12. Ghevaert C, Campbell K, Walton J, Smith GA, Allen D, Williamson LM, Ouwehand WH, Ranasinghe E:Management and outcome of 200 cases of fetomaternal alloimmune thrombocytopenia. Transfusion 2007 47:901 910
13. Hurd CM, Cavanagh G, Schuh A, Ouwehand WH, Metcalfe P:Genotyping for platelet-specific antigens: techniques for the detection of single nucleotide polymorphisms. Vox Sang 2002 83:1 12
14. Bugert P, McBride S, Smith G, Dugrillon A, Kluter H, Ouwehand WH, Metcalfe P:Microarray-based genotyping for blood groups: comparison of gene array and 5′-nuclease assay techniques with human platelet antigen as a model. Transfusion 2005 45:654 659
15. Hertzberg M, Neville S, Favaloro E, McDonald D:External quality assurance of DNA testing for thrombophilia mutations. Am J Clin Pathol 2005 123:189 193
16. Tripodi A, Peyvandi F, Chantarangkul V, Menegatti M, Mannucci PM:Relatively poor performance of clinical laboratories for DNA analyses in the detection of two thrombophilic mutations - a cause for concern. Thromb Haemost 2002 88:690 691
17. Preston FE, Kitchen S, Jennings I, Woods TA:A UK National External Quality Assessment scheme (UK Neqas) for molecular genetic testing for the diagnosis of familial thrombophilia. Thromb Haemost 1999 82:1556 1557